Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
0,34 HKD | -1,45% | -6,85% | -45,16% |
Attività
Numero di dipendenti: 387
Vendite per attività
HKD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Innovative Vaccines
100,0
%
| 0 | nan % | 43 | 100,0 % | - |
Vendite per regione
HKD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China
100,0
%
| 0 | nan % | 43 | 100,0 % | - |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Joshua Liang
CEO | Chief Executive Officer | - | 25/12/20 |
Aileen Wang
DFI | Director of Finance/CFO | - | 01/03/21 |
Htay Htay Han
CTO | Chief Tech/Sci/R&D Officer | 56 | 03/02/21 |
Wang Xiaoyan
SEC | Corporate Secretary | - | 31/03/23 |
Lily Yang
HRO | Human Resources Officer | - | 01/05/21 |
Liong Ho Chua
PRN | Corporate Officer/Principal | 60 | 27/04/22 |
Xiao Bing Li
PRN | Corporate Officer/Principal | 56 | 27/07/20 |
Hing Ling Chau
SEC | Corporate Secretary | 49 | 22/12/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Jeffrey Farrow
BRD | Director/Board Member | 62 | 19/04/21 |
Xiao Dong Wang
BRD | Director/Board Member | 61 | 16/03/21 |
Xiao Bin Wu
BRD | Director/Board Member | 62 | 19/04/21 |
Donna Ambrosino
BRD | Director/Board Member | 72 | 17/06/22 |
Ralf Clemens
BRD | Director/Board Member | 71 | 17/06/22 |
Thomas Leggett
BRD | Director/Board Member | 47 | 19/04/21 |
Peng Liang
CHM | Chairman | 63 | 31/10/18 |
Joshua Liang
CEO | Chief Executive Officer | - | 25/12/20 |
Xiang Liao
BRD | Director/Board Member | 59 | 19/04/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 1 297 047 429 | 634 370 609 ( 48,91 %) | 0 | 48,91 % |
Coordinate società
Clover Biopharmaceuticals Ltd.
49F, Park Place 1598-1601 West Nanjing Road
200010, Shanghai
+
http://www.cloverbiopharma.comSettore
Vendite per regione
Fatturato trimestrale - Indice di sorpresa
Variaz. 1 gen. | Capi. | |
---|---|---|
-45,16% | 57,3 Mln | |
+16,30% | 122 Mrd | |
+19,84% | 113 Mrd | |
+17,29% | 26,49 Mrd | |
-23,63% | 19,4 Mrd | |
-19,14% | 16,24 Mrd | |
-19,61% | 15,4 Mrd | |
-45,95% | 15,15 Mrd | |
+63,69% | 14,93 Mrd | |
+3,79% | 13,52 Mrd |
- Borsa valori
- Azioni
- Azione 2197
- Società Clover Biopharmaceuticals, Ltd.